In melanoma models, both monotherapy and dexamethasone combination therapy demonstrated significant tumor growth inhibition through coordinated blockade of STAT3 phosphorylation (Y705/S727) and consequent downregulation of nuclear and mitochondrial STAT3-dependent transcription (Dinarello et al., 2023). Here, STAT3 is linked to neoplasm.